These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37996012)

  • 41. Searching for a new anti-HCV therapy: synthesis and properties of tropolone derivatives.
    Boguszewska-Chachulska AM; Krawczyk M; Najda A; Kopańska K; Stankiewicz-Drogoń A; Zagórski-Ostoja W; Bretner M
    Biochem Biophys Res Commun; 2006 Mar; 341(2):641-7. PubMed ID: 16438939
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The furan route to tropolones: probing the antiproliferative effects of β-thujaplicin analogs.
    Oblak EZ; Bolstad ES; Ononye SN; Priestley ND; Hadden MK; Wright DL
    Org Biomol Chem; 2012 Nov; 10(43):8597-604. PubMed ID: 23032214
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Studies on the anti-hepatitis C virus activity of newly synthesized tropolone derivatives: identification of NS3 helicase inhibitors that specifically inhibit subgenomic HCV replication.
    Najda-Bernatowicz A; Krawczyk M; Stankiewicz-Drogoń A; Bretner M; Boguszewska-Chachulska AM
    Bioorg Med Chem; 2010 Jul; 18(14):5129-36. PubMed ID: 20579888
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antiviral activity of various 1-(2'-deoxy-β-D-lyxofuranosyl), 1-(2'-fluoro-β-D-xylofuranosyl), 1-(3'-fluoro-β-D-arabinofuranosyl), and 2'-fluoro-2',3'-didehydro-2',3'-dideoxyribose pyrimidine nucleoside analogues against duck hepatitis B virus (DHBV) and human hepatitis B virus (HBV) replication.
    Srivastav NC; Shakya N; Mak M; Agrawal B; Tyrrell DL; Kumar R
    J Med Chem; 2010 Oct; 53(19):7156-66. PubMed ID: 20857959
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and biological evaluation of O-alkylated tropolones and related alpha-ketohydroxy derivatives as ribonucleotide reductase inhibitors.
    Tamburlin-Thumin I; Crozet MP; Barrière JC; Barreau M; Riou JF; Lavelle F
    Eur J Med Chem; 2001 Jun; 36(6):561-8. PubMed ID: 11525847
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Design, synthesis, and biological evaluation of new 1,2,3-triazolo-2'-deoxy-2'-fluoro- 4'-azido nucleoside derivatives as potent anti-HBV agents.
    Liu Y; Peng Y; Lu J; Wang J; Ma H; Song C; Liu B; Qiao Y; Yu W; Wu J; Chang J
    Eur J Med Chem; 2018 Jan; 143():137-149. PubMed ID: 29174810
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antihepatitis B therapy: a review of current medications and novel small molecule inhibitors.
    Qiu LP; Chen L; Chen KP
    Fundam Clin Pharmacol; 2014 Aug; 28(4):364-81. PubMed ID: 24118072
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduction of hepatitis B surface antigen and covalently closed circular DNA by nucleos(t)ide analogues of different potency.
    Wong DK; Seto WK; Fung J; Ip P; Huang FY; Lai CL; Yuen MF
    Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1004-10.e1. PubMed ID: 23376799
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis, structure-activity relationships and biological evaluation of caudatin derivatives as novel anti-hepatitis B virus agents.
    Wang LJ; Geng CA; Ma YB; Huang XY; Luo J; Chen H; Guo RH; Zhang XM; Chen JJ
    Bioorg Med Chem; 2012 May; 20(9):2877-88. PubMed ID: 22472044
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of various pyrimidines possessing the 1-[(2-hydroxy-1-(hydroxymethyl)ethoxy)methyl] moiety, able to mimic natural 2'-deoxyribose, on wild-type and mutant hepatitis B virus replication.
    Kumar R; Semaine W; Johar M; Tyrrell DL; Agrawal B
    J Med Chem; 2006 Jun; 49(12):3693-700. PubMed ID: 16759112
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator against Hepatitis B Virus.
    Lam AM; Espiritu C; Vogel R; Ren S; Lau V; Kelly M; Kuduk SD; Hartman GD; Flores OA; Klumpp K
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373799
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discovery of New Small Molecule Hits as Hepatitis B Virus Capsid Assembly Modulators: Structure and Pharmacophore-Based Approaches.
    Senaweera S; Du H; Zhang H; Kirby KA; Tedbury PR; Xie J; Sarafianos SG; Wang Z
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33925540
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Variability in the Responses of Hepatitis B Virus D-Subgenotypes to Antiviral Therapy: Designing Pan-D-Subgenotypic Reverse Transcriptase Inhibitors.
    Khatun M; Kumar K; Baidya A; Mondal RK; Baszczyňski O; Kalčic F; Banerjee S; Dhali GK; Das K; Chowdhury A; Janeba Z; Chakrabarti S; Datta S
    J Virol; 2022 Jan; 96(2):e0180021. PubMed ID: 34730399
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of hepatitis B virus replication by N-hydroxyisoquinolinediones and related polyoxygenated heterocycles.
    Edwards TC; Lomonosova E; Patel JA; Li Q; Villa JA; Gupta AK; Morrison LA; Bailly F; Cotelle P; Giannakopoulou E; Zoidis G; Tavis JE
    Antiviral Res; 2017 Jul; 143():205-217. PubMed ID: 28450058
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design, synthesis and evaluation of heteroaryldihydropyrimidine analogues bearing spiro ring as hepatitis B virus capsid protein inhibitors.
    Ma Y; Zhao S; Ren Y; Cherukupalli S; Li Q; Woodson ME; Bradley DP; Tavis JE; Liu X; Zhan P
    Eur J Med Chem; 2021 Dec; 225():113780. PubMed ID: 34438123
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular mechanisms of resistance to antiviral therapy in patients with chronic hepatitis B.
    Yuan HJ; Lee WM
    Curr Mol Med; 2007 Mar; 7(2):185-97. PubMed ID: 17346170
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel method for nucleos(t)ide analogues susceptibility assay of hepatitis B virus by viral polymerase transcomplementation.
    Luo YY; Tao Y; Cai XF; Zhang WL; Long QX; Guo H; Huang AL; Hu JL
    Antiviral Res; 2016 Feb; 126():99-107. PubMed ID: 26738784
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues.
    Boni C; Laccabue D; Lampertico P; Giuberti T; Viganò M; Schivazappa S; Alfieri A; Pesci M; Gaeta GB; Brancaccio G; Colombo M; Missale G; Ferrari C
    Gastroenterology; 2012 Oct; 143(4):963-73.e9. PubMed ID: 22796241
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
    Buster EH; van Erpecum KJ; Schalm SW; Zaaijer HL; Brouwer JT; Gelderblom HC; de Knegt RJ; Minke Bakker C; Reesink HW; Janssen HL;
    Neth J Med; 2008; 66(7):292-306. PubMed ID: 18663260
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibacterial activity of selected tropones and tropolones.
    Saleh NA; Zwiefak A; Mordarski M; Pulverer G
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov; 270(1-2):160-70. PubMed ID: 3223137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.